ADVERTISEMENT



Google       

Home -> Law Blog Directory -> Patent Law Blogs -> IPBiz

OR PHONE (866) 635-1838 for Bankruptcy Help, (866) 635-6190 for Divorce,
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense

Find a Local Lawyer

Bankruptcy (866) 635-1838
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402

Bookmark

Patent Law

: IPBiz

Ranbaxy, AstraZeneca settle over Nexium

By Lawrence B. Ebert, Esq.

ADVERTISEMENTS
On April 14, 2008, AstraZeneca announced a settlement with Ranbaxy over the Hatch-Waxman litigation concerning Nexium.

The WSJ reported:

The settlement means that Ranbaxy will be able to begin selling a generic version of Nexium from May 27, 2014. "Under the settlement agreement, Ranbaxy concedes that all six patents asserted by AstraZeneca in the patent litigation are valid and enforceable," said AstraZeneca in a statement. "Ranbaxy also accepts that four of the patents would be infringed by the unlicensed sale of Ranbaxy's proposed generic product."

Full post as published by IPBiz on April 15, 2008 (boomark / email).

Bloggers, promote your law blog by nominating your blog for inclusion in USLaw.com's Law Blog Directory and RSS Reader. Benefits described.
Lawsuits and Settlements

Related Searches

























































































































US Law
#1 Online Legal Resource













Your Blog Subscriptions
Subscribe to blogs

10,000+ Law Job Listings
Lawyer . Police . Paralegal . Etc
Earn a law-related degree
Are you the author of this blog? Adding USLaw.com to your Blogroll increases relevance. You qualify to display a USLaw Network badge.
Suggest changes to this blog's description or nominate another for inclusion. Register for updates.


Practice Area
Zip Code:

Contact a Lawyer Now!






0.0133 secs (new cache)